GeneDx Holdings (WGS) Deferred Taxes (2022 - 2026)
GeneDx Holdings' (WGS) quarterly Deferred Taxes came in at -$518000.0 in Q2 2026, down 111.43% year-over-year from $4.5 million in Q2 2025, and down 157.75% quarter-over-quarter from $897000.0 in Q1 2026.
Powered by 
Analysis
GeneDx Holdings (WGS) Deferred Taxes (2022 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Deferred Taxes for 5 consecutive years, with -$518000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Deferred Taxes fell 111.43% year-over-year to -$518000.0 in Q2 2026; TTM through Jun 2026 was $380000.0, a 190.08% increase from a year earlier, with the FY2024 full-year figure at -$343000.0, up 62.96% from the prior year.
- Deferred Taxes was -$518000.0 for Q2 2026 at GeneDx Holdings, down from $897000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $897000.0 in Q1 2026 and troughed at -$49.1 million in Q2 2022.
- A 5-year average of -$3.1 million and a median of -$123000.0 in 2022 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes sank 890.38% in 2023 and jumped 645.12% in 2025, its largest moves.
- Over 5 years, Deferred Taxes stood at $52000.0 in 2022, then slumped by 890.38% to -$411000.0 in 2023, then surged by 94.16% to -$24000.0 in 2024, then surged by 1125.0% to $246000.0 in 2025, then slumped by 310.57% to -$518000.0 in 2026.
- The last three Deferred Taxes figures came in at -$518000.0 (Q2 2026), $897000.0 (Q1 2026), and $246000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -2.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -24.40 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 9.63 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | - |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -518,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -518,000.00 |
| Mar 31, 2026 | 897,000.00 |
| Sep 30, 2025 | 246,000.00 |
| Jun 30, 2025 | -245,000.00 |
| Mar 31, 2025 | 447,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Sep 30, 2024 | -47,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Dec 31, 2023 | -411,000.00 |
| Sep 30, 2023 | -172,000.00 |
| Jun 30, 2023 | -196,000.00 |
| Mar 31, 2023 | -147,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | -99,000.00 |
| Jun 30, 2022 | -49.08 Mn |